Cosignaling Molecules Around LIGHT-HVEM-BTLA: From Immune Activation to Therapeutic Targeting

E-ISSN： 1875-5666|9|7|911-927

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.9, Iss.7, 2009-09, pp. : 911-927

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New hope for spinal-cord repair from immune activation

By Gurwitz D.

Molecular Medicine Today, Vol. 6, Iss. 11, 2000-11 ,pp. : 415-415

Elsevier

Access to resources Recommend Favorite

New Drugs for Immune Targeting

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 118-130

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Adhesion Molecules in Cardiovascular Disorders

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 8, Iss. 4, 2008-01 ,pp. : 252-260

Bentham Science Publishers

Access to resources Recommend Favorite

Immune regulation by novel costimulatory molecules

By Dong Chen Nurieva Roza Prasad Durbaka

Immunologic Research, Vol. 28, Iss. 1, 2003-08 ,pp. : 39-48

Humana Press, Inc

Access to resources Recommend Favorite

Recent Advances in Delivery of Cytokines, Growth Factors, and Molecules of Therapeutic Interest from Hyaluronan-based Hydrogels

Current Tissue Engineering, Vol. 4, Iss. 1, 2015-04 ,pp. : 47-56

Bentham Science Publishers

Access to resources Recommend Favorite